Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for Jasper Therapeutics, Inc. Voting Common Stock (JSPR).
- Disclosed ownership: 2.8%.
- Date of event: 30 Sep 2025.
MORGAN STANLEY - 30 Sep 2025 SCHEDULE 13G/A Report for Jasper Therapeutics, Inc. Voting Common Stock (JSPR)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- JSPR
- Shares outstanding
- 28,022,429 shares
- Disclosed Ownership
- 784,628 shares
- Ownership
- 2.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Nov 2025, 12:45:44 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 06 Aug 2025
- Next filing
- 11 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 2.8% ownership in Jasper Therapeutics, Inc. Voting Common Stock (JSPR) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 06 Aug 2025.
- Current filing was accepted on 07 Nov 2025, 12:45.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 2.8% | 784,628 | 0 | 784,428 | Christopher O'Hara | Authorized Signatory, Morgan Stanley |